 RICHLAND, Wash., March 31, 2021 GLOBE NEWSWIRE -- A recently published small prospective series of patients with recurrent head and neck HN cancers treated with surgical resection and Isorays Cesium-131 brachytherapy found potential benefits that support further research into combination therapy with Cesium-131 brachytherapy and surgical resection. 